• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. GlaxoSmithKline Files US Regulatory Application for Sirukumab in Rheumatoid Arthritis

    GlaxoSmithKline Files US Regulatory Application for Sirukumab in Rheumatoid Arthritis

  2. FTSE 100 becalmed as traders wait for central banks

    FTSE 100 becalmed as traders wait for central banks

  3. Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, With Asthma and Cystic Fibrosis Leading the Way - Research and Markets

    Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, With Asthma and Cystic Fibrosis Leading the Way - Research and Markets

  4. Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress

    Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress

  5. UPDATE: FTSE 100 higher as investors wait for U.S. jobs report

    UPDATE: FTSE 100 higher as investors wait for U.S. jobs report

  6. LONDON MARKETS: FTSE 100 Higher As Investors Wait For U.S. Jobs Report

    LONDON MARKETS: FTSE 100 Higher As Investors Wait For U.S. Jobs Report

  7. LONDON MARKETS: FTSE 100 Logs Best Day In 2 Months As U.S. Jobs Data Seen Delaying Rate Hike

    LONDON MARKETS: FTSE 100 Logs Best Day In 2 Months As U.S. Jobs Data Seen Delaying Rate Hike

  8. UPDATE: FTSE 100 logs best day in 2 months as U.S. jobs data seen delaying rate hike

    UPDATE: FTSE 100 logs best day in 2 months as U.S. jobs data seen delaying rate hike

  9. Vaccine Market Worth $77.5 Billion by 2024 - Analysis By Type & Application - Research and Markets

    Vaccine Market Worth $77.5 Billion by 2024 - Analysis By Type & Application - Research and Markets

  10. Infectious Disease Treatment Market in China 2016-2020 - Emergence of Interferon Free Therapies - Research and Markets

    Infectious Disease Treatment Market in China 2016-2020 - Emergence of Interferon Free Therapies - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.